Simulations Plus to Present at the Sidoti & Company, LLC Semi-Annual New York Micro-Cap Conference
-- Leader in Drug Discovery and Development Simulation and Modeling Software to Present on January 9, 2012 --
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, today announced that Walt Woltosz, chairman and chief executive officer, will present at the Sidoti & Company Semi-Annual New York Micro-Cap Conference at 1:20 p.m. ET on Monday, January 9, 2012 in the Estate 3/Alvin room at the Grand Hyatt New York Hotel. Simulations Plus management will be available during the day for one-on-one meetings. To schedule a meeting, please contact your Sidoti representative.
A copy of the investor presentation that will accompany managements group presentation will be available at the Simulations Plus corporate website (www.simulations-plus.com) prior to the presentation.
Sidoti & Company, LLC
Sidoti & Company, LLC Micro-Cap Conference is one of the largest micro-cap focused investor events in the U.S., with over 400 institutional investor attendees at the previous micro-cap conference. For more information or to register for the conference, please visit http://microcap.sidoti.com.
About Simulations Plus, Inc.
Simulations Plus, Inc. is a premier developer of groundbreaking drug discovery and development simulation and modeling software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. Simulations Plus, Inc., is headquartered in Southern California and trades on the NASDAQ Capital Market under the symbol SLP. For more information, visit our Web site at www.simulations-plus.com.
Simulations Plus Investor Relations
Ms. Renee Bouche, 661-723-7723
Mr. Cameron Donahue, 651-653-1854
Source: Simulations Plus, Inc.Copyright Business Wire 2011